ULK3 Gene

ULK3 Gene

Introduction

Ulk3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<nav class="infobox .infobox-gene">
| ULK3 Gene | |
|---|---|
| Full Name | Unc-51 Like Kinase 3 |
| Symbol | ULK3 |
| Chromosome | 19q13.43 |
| NCBI Gene ID | 54586 |
| OMIM | 608866 |
| Ensembl ID | ENSG00000140474 |
| UniProt | Q6ZNE5 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Autism Spectrum Disorder, Glioblastoma |
</nav>

Overview

ULK3 Gene

Introduction

Ulk3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<nav class="infobox .infobox-gene">
| ULK3 Gene | |
|---|---|
| Full Name | Unc-51 Like Kinase 3 |
| Symbol | ULK3 |
| Chromosome | 19q13.43 |
| NCBI Gene ID | 54586 |
| OMIM | 608866 |
| Ensembl ID | ENSG00000140474 |
| UniProt | Q6ZNE5 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Autism Spectrum Disorder, Glioblastoma |
</nav>

Overview

The ULK3 gene encodes ULK3 (Unc-51 Like Kinase 3), a serine/threonine protein kinase belonging to the ULK (Unc-51-like kinase) family. ULK3 plays crucial roles in autophagy initiation, cellular stress responses, and has been implicated in various neurodegenerative diseases["@chan2017"]. ULK3 is one of three mammalian ULK kinases (ULK1, ULK2, and ULK3) that serve as master regulators of autophagy, the cellular process responsible for degrading and recycling damaged organelles and protein aggregates.

The ULK Kinase Family

The ULK family consists of three paralogs with distinct and overlapping functions:

| Kinase | Gene | Chromosome | Primary Function |
|--------|------|------------|-----------------|
| ULK1 | ULK1 | 12q24.31 | Major autophagy initiator |
| ULK2 | ULK2 | 19q13.43 | Redundant with ULK1 |
| ULK3 | ULK3 | 19q13.43 | Stress-responsive, non-canonical autophagy |

ULK1 vs ULK2 vs ULK3

• ULK1: Primary autophagy initiator, phosphorylated by AMPK
• ULK2: Partially redundant with ULK1, compensation possible
• ULK3: Distinct functions in stress response, can initiate autophagy independently of [mTOR](/entities/mtor)

Protein Structure

ULK3 contains several functional domains:

• N-terminal kinase domain - Ser/Thr kinase activity
• C-terminal domain - Regulatory functions
• LC3-interacting region (LIR) - Binds autophagy proteins
• Proline-rich regions - Protein-protein interactions

Molecular Function

Autophagy Initiation

ULK3 can initiate autophagy through multiple mechanisms[@mizushima2008]:

• ATG14L (ATG14) - Promotes autophagy initiation
• Beclin 1 - PI3K complex activation
• LC3 - Lipidation and autophagosome formation

• mTOR inhibition
• AMPK activation

Stress Response

ULK3 responds to various cellular stresses:

• Energy depletion: Activated when AMP/ATP ratio increases
• ER stress: Responds to unfolded protein accumulation
• Oxidative stress: Activated by [reactive oxygen species](/entities/reactive-oxygen-species)
• Hypoxia: Regulated by oxygen-sensing mechanisms

Signaling Integration

ULK3 integrates signals from multiple pathways:

• AMPK pathway: Energy sensing via AMPK
• mTOR pathway: Nutrient signaling inhibition
• p53 pathway: DNA damage response
• Inflammatory signaling: Links autophagy to immunity

Expression Pattern

Brain Expression

ULK3 is expressed in various brain regions:

• Cerebral [cortex](/brain-regions/cortex) - [Neurons](/entities/neurons) and glia
• [Hippocampus](/brain-regions/hippocampus) - CA regions, dentate gyrus
• Cerebellum - Purkinje cells
• Substantia nigra - Dopaminergic neurons
• Hypothalamus - Neuroendocrine cells

Cell Type Specificity

• Neurons: Moderate to high expression
• [Astrocytes](/entities/astrocytes): High expression for stress response
• [Microglia](/entities/microglia): Induced under stress
• Oligodendrocytes: Lower expression

Disease Associations

Alzheimer's Disease (AD)

ULK3 dysfunction contributes to AD pathogenesis[@nixon2013]:

[Autophagy](/entities/autophagy) Impairment:

• Reduced ULK3 activity in AD brain
• Impaired clearance of [amyloid-beta](/proteins/amyloid-beta) plaques
• Decreased [tau](/proteins/tau) clearance
• Accumulation of autophagic vacuoles

• ULK3 activators may enhance Aβ clearance
• Combination with mTOR inhibitors
• Gene therapy approaches

Parkinson's Disease (PD)

ULK3 plays a role in PD through:

Mitophagy:

• ULK3 participates in PINK1/Parkin mitophagy
• Clearance of damaged mitochondria
• Protection of dopaminergic neurons

• Autophagy-mediated degradation
• Reduced aggregation
• Neuroprotection

Autism Spectrum Disorder (ASD)

Emerging evidence links ULK3 to ASD:

• Genetic variants in ULK3 associated with ASD
• Synaptic autophagy deficits
• Neuronal development abnormalities
• Social behavior dysfunction in models

Cancer

ULK3 has context-dependent roles in cancer:

• Tumor suppressor in glioblastoma
• Oncogenic potential in some cancers
• Autophagy modulation affects tumor growth
• Therapeutic targeting under investigation

Therapeutic Implications

Pharmacological Approaches

| Approach | Compound | Mechanism | Status |
|----------|----------|-----------|--------|
| ULK3 activator | LYN-1604 | Direct ULK3 activation | Preclinical |
| mTOR inhibitor | Rapamycin | Indirect ULK3 activation | Approved |
| Autophagy inducer | Trehalose | ULK-independent | Preclinical |
| AMPK activator | AICAR | ULK activation | Research |

Gene Therapy

• ULK3 overexpression: Protective in models
• AAV delivery: Targeted to neurons
• CRISPR activation: Epigenetic approaches

Combination Therapy

• mTOR + autophagy induction: Synergistic effects
• ULK3 + clearance enhancers: Enhanced protein removal
• Anti-aggregation + induction: Multi-target approach

Research Techniques

Experimental Methods

• Knockout mice: Ulk3 deletion studies
• CRISPR/Cas9: Genetic manipulation
• Phosphorylation assays: Kinase activity
• Autophagy flux measurement: LC3 turnover
• Electron microscopy: Autophagosome visualization

Biomarkers

• ULK3 phosphorylation - Activity indicator
• ATG14L phosphorylation - Downstream target
• Autophagy markers - LC3, p62

See Also

• [ULK1 Gene](/proteins/ulk1-protein)
• [ULK2 Gene](/proteins/ulk2-protein)
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [mTOR Signaling Pathway](/mechanisms/mtor-signaling-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitophagy Pathway](/mechanisms/mitophagy-pathway)

External Links

• [NCBI Gene: ULK3](https://www.ncbi.nlm.nih.gov/gene/54586)
• [UniProt: Q6ZNE5](https://www.uniprot.org/uniprot/Q6ZNE5)
• [HGNC: ULK3](https://www.genenames.org/data/hgnc_data.php?hgnc_id=17892)
• [OMIM: 608866](https://www.omim.org/entry/608866)

Background

The study of Ulk3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ULK3 Gene discovered through SciDEX knowledge graph analysis: